MedCity News
APRIL 21, 2024
Solera Health added Ciba Health, Digbi Health and Wondr Health to its HALO platform. The companies treat conditions like hypertension and diabetes. The post Solera Health Expands Platform To Address Cardiometabolic Conditions appeared first on MedCity News.
pharmaphorum
APRIL 21, 2024
CSL Vifor offers a communication campaign to answer EU allegations it disparaged a rival iron deficiency treatment from Pharmacosmos.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
APRIL 21, 2024
Routine NM-MRI for individuals at risk of Parkinson’s could provide a means of identifying the disease before symptoms emerge. The post Realizing the Promise of Neuromelanin-Sensitive MRI (NM-MRI) appeared first on MedCity News.
pharmaphorum
APRIL 21, 2024
Generics of Astellas’ Myrbetriq for urinary incontinence are looming in the US after a court recommended against an injunction on copycats from Zydus and Lupin
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
MedCity News
APRIL 21, 2024
We must look both “upstream” – at advocating for change on an institutional level – and “downstream” – at what we can do as individuals to help women secure the care they need. The post To Continue the Momentum in Women’s Health, We Have No Time to Lose appeared first on MedCity News.
PharmaTech
APRIL 21, 2024
Webinar Date/Time: Tue, Jun 11, 2024 10:00 AM EDT
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmacy Times
APRIL 21, 2024
Integration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.
MedCity News
APRIL 21, 2024
As cell and gene therapies continue to make headlines as a key opportunity for growth, success in this field will require both innovative tech as well as strategic foresight. The post Portfolio Management Strategies for Growth and Impact in Cell and Gene appeared first on MedCity News.
Expert insights. Personalized for you.
121 
Let's personalize your content